Gastric Cancer
Research conducted at School of Medicine, Department of Pharmacology has updated our knowledge about gastric cancer
Published in Drug Law Weekly, August 7th, 2007
Scientists discuss in "Reversal of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR by LY980503" new findings in gastric cancer. In this recently published article, scientists in People's Republic of China conducted a study "To investigate the reversal effect of LY980503, a benflumetol derivative, on multidrug resistance in vincristine (VCR) -resistant human gastric carcinoma cell line SGC7901/VCR. Cells of a human gastric cancer cell line, SGC7901, and its VCR-resistant variant, SGC7901/VCR, were cultivated with LY980503 and /or doxorubicin (DOX)."
"The cytotoxicity of drugs in vitro was assayed by MTT method. Based on the flow...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-08-07)
More Articles from Drug Law Weekly
- Addiction Medicine
Reports from University Hospital advance knowledge in addiction medicine - Addictive Behavior Therapy
Reports summarize addictive behavior therapy research from Texas Christian University - Bird Flu
The Quigley Corporation Reports Second Quarter Results; Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy - Cancer Research
Barr Confirms Patent Challenge of TEMODAR - Chagas Disease
Oswaldo Cruz Foundation and Genzyme Corporation Form Collaboration To Advance New Drugs for Neglected Diseases - Clinical Trial Research
Clinical Data Announces Exercise of Underwriters' Over-Allotment Option - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
